share_log

Intelligent Bio Solutions | 8-K: Current report

Intelligent Bio Solutions | 8-K:重大事件

美股SEC公告 ·  03/01 16:21
Moomoo AI 已提取核心訊息
On February 29, 2024, Intelligent Bio Solutions Inc., a Delaware-incorporated company listed on The Nasdaq Stock Market under the symbol INBS, reported entering into two separate agreements to enhance its advisory and investor relations services. The first agreement, with C2C Advisors Inc., involves a 6-month term where C2C will provide advisory services for a monthly fee of $25,000 and a one-time grant of 37,500 restricted shares of common stock. The second agreement, with ClearThink Capital LLC, includes an initial grant of 5,260 restricted shares and a monthly fee of $5,000 plus $4,000 worth of restricted common stock, calculated quarterly. Both agreements are effective as of February 29, 2024, with the ClearThink Agreement allowing for termination by either party after three months. The shares from both agreements will be issued under an exemption from registration according to Section 4(a)(2) of the Securities Act of 1933.
On February 29, 2024, Intelligent Bio Solutions Inc., a Delaware-incorporated company listed on The Nasdaq Stock Market under the symbol INBS, reported entering into two separate agreements to enhance its advisory and investor relations services. The first agreement, with C2C Advisors Inc., involves a 6-month term where C2C will provide advisory services for a monthly fee of $25,000 and a one-time grant of 37,500 restricted shares of common stock. The second agreement, with ClearThink Capital LLC, includes an initial grant of 5,260 restricted shares and a monthly fee of $5,000 plus $4,000 worth of restricted common stock, calculated quarterly. Both agreements are effective as of February 29, 2024, with the ClearThink Agreement allowing for termination by either party after three months. The shares from both agreements will be issued under an exemption from registration according to Section 4(a)(2) of the Securities Act of 1933.
2024年2月29日,在納斯達克股票市場上市的特拉華州註冊公司Intelligent Bio Solutions Inc. 報告說,已簽訂兩份單獨的協議,以加強其諮詢和投資者關係服務。與C2C Advisors Inc.簽訂的第一份協議涉及6個月的期限,其中C2C將提供諮詢服務,月費爲25,000美元,並一次性授予37,500股限制性普通股。與ClearThink Capital LLC簽訂的第二份協議包括初始授予5,260股限制性股票和5,000美元的月費外加價值4,000美元的限制性普通股,按季度計算。這兩項協議均自2024年2月29日起生效,ClearThink協議允許任何一方在三個月後終止。根據1933年《證券法》第4(a)(2)條,這兩份協議中的股票將在註冊豁免的情況下發行。
2024年2月29日,在納斯達克股票市場上市的特拉華州註冊公司Intelligent Bio Solutions Inc. 報告說,已簽訂兩份單獨的協議,以加強其諮詢和投資者關係服務。與C2C Advisors Inc.簽訂的第一份協議涉及6個月的期限,其中C2C將提供諮詢服務,月費爲25,000美元,並一次性授予37,500股限制性普通股。與ClearThink Capital LLC簽訂的第二份協議包括初始授予5,260股限制性股票和5,000美元的月費外加價值4,000美元的限制性普通股,按季度計算。這兩項協議均自2024年2月29日起生效,ClearThink協議允許任何一方在三個月後終止。根據1933年《證券法》第4(a)(2)條,這兩份協議中的股票將在註冊豁免的情況下發行。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息